Genetic Testing Services Market
Genetic Testing Services Market Analysis by Prenatal Testing, New Born Screening, Predictive & Presymptomatic Testing, and Pharmacogenomic Testing from 2023 to 2033
Analysis of Genetic Testing Services Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Table of Content
1. Preface 1.1. Report Scope and Market Segmentation 1.2. Research Highlights 2. Assumptions and Research Methodology 2.1. Assumptions and Acronyms Used 2.2. Research Methodology 3. Executive Summary 3.1. Global Market Size (US$ Mn) and Forecast, by Region, 2023 and 2033 3.2. Global Market: Market Snapshot 4. Market Overview 4.1. Global Market Overview 4.2. Global Market Key Industry Developments 4.3. Key Industry Events 5. Market Dynamics 5.1. Drivers and Restraints Snapshot Analysis 5.2. Drivers 5.3. Restraints 5.4. Opportunities 5.5. Key Trends 5.6. Global Market Revenue Projections (US$ Mn), 2023–2033 5.7. Market: Mergers & Acquisitions 5.8. Heat Map Analysis - Company 6. Global Market Analysis, by Test Type 6.1. Introduction 6.2. Key Insights 6.3. Global Market Size and Forecast, by Test Type 6.3.1. Prenatal Testing Services 6.3.2. New Born Screening 6.3.3. Predictive and Presymptomatic Testing 6.3.4. Pharmacogenomic Testing 6.3.5. Others 6.4. Global Market Analysis, by Test Type 6.5. Global Market Attractiveness Analysis, by Test Type 7. Global Market Analysis, by Service Providers 7.1. Introduction 7.2. Key Insights 7.3. Global Market Size and Forecast, by Service Providers 7.3.1. Hospital Based Laboratories 7.3.2. Diagnostic laboratories 7.3.3. Specialty Clinics 7.3.4. Others 7.4. Global Market Analysis, by Service Providers 7.5. Global Market Attractiveness Analysis, by Service Providers 8. Global Market Analysis, by Applications 8.1. Introduction 8.2. Key Insights 8.3. Global Market Size and Forecast, by Applications 8.3.1. Oncology 8.3.2. Infectious Diseases 8.3.3. Autoimmune Diseases 8.3.4. Others 8.4. Global Market Analysis, by Applications 8.5. Global Market Attractiveness Analysis, by Applications 9. Global Market Analysis, by Region 9.1. Introduction 9.2. Key Insights 9.3. Global Market Size and Forecast , by Region, 2023–2033 9.3.1. North America 9.3.2. Europe 9.3.3. Asia Pacific 9.3.4. Latin America 9.3.5. Middle East & Africa 9.4. Global Market Analysis, by Region 9.5. Global Market Attractiveness Analysis, by Region 10. North America Market Analysis 10.1. North America Market Key Findings 10.2. North America Market Overview 10.3. North America Market Size and Forecast, by Test Type 10.3.1. Prenatal Testing Services 10.3.2. New Born Screening 10.3.3. Predictive and Presymptomatic Testing 10.3.4. Pharmacogenomic Testing 10.3.5. Others 10.3.6. North America Market Analysis, by Test Type 10.4. North America Market Size and Forecast, by Service Providers 10.4.1. Hospital Based Laboratories 10.4.2. Diagnostic laboratories 10.4.3. Specialty Clinics 10.4.4. Others 10.5. North America Market Forecast, by Applications 10.5.1. Oncology 10.5.2. Infectious Diseases 10.5.3. Autoimmune Diseases 10.5.4. Others 10.6. North America Market Forecast, by Country 10.6.1. U.S. 10.6.2. Canada 10.7. North America Market Attractiveness Analysis 10.7.1. By Test Type 10.7.2. By Service Providers 10.7.3. By Applications 10.7.4. By Country 11. Europe Market Analysis 11.1. Europe Market Key Findings 11.2. Europe Market Overview 11.3. Europe Market Size and Forecast, by Test Type 11.3.1. Prenatal Testing Services 11.3.2. New Born Screening 11.3.3. Predictive and Presymptomatic Testing 11.3.4. Pharmacogenomic Testing 11.3.5. Others 11.4. Europe Market Size and Forecast, by Service Providers 11.4.1. Hospital Based Laboratories 11.4.2. Diagnostic laboratories 11.4.3. Specialty Clinics 11.4.4. Others 11.5. Europe Market Forecast, by Applications 11.5.1. Oncology 11.5.2. Infectious Diseases 11.5.3. Autoimmune Diseases 11.5.4. Others 11.6. Europe Market Forecast, by Country 11.6.1. Germany 11.6.2. U.K. 11.6.3. France 11.6.4. Spain 11.6.5. Italy 11.6.6. Rest of Europe 11.7. Europe Market Attractiveness Analysis 11.7.1. By Test Type 11.7.2. By Service Providers 11.7.3. By Applications 11.7.4. By Country 12. Asia Pacific Market Analysis 12.1. Asia Pacific Market Key Findings 12.2. Asia Pacific Market Overview 12.3. Asia Pacific Cytometry Market Size and Forecast, by Test Type 12.3.1. Prenatal Testing Services 12.3.2. New Born Screening 12.3.3. Predictive and Presymptomatic Testing 12.3.4. Pharmacogenomic Testing 12.3.5. Others 12.4. Asia Pacific Market Size and Forecast, by Service Providers 12.4.1. Hospital Based Laboratories 12.4.2. Diagnostic laboratories 12.4.3. Specialty Clinics 12.4.4. Others 12.5. Asia Pacific Market Forecast, by Applications 12.5.1. Oncology 12.5.2. Infectious Diseases 12.5.3. Autoimmune Diseases 12.5.4. Others 12.6. Asia Pacific Market Forecast, by Country 12.6.1. China 12.6.2. India 12.6.3. Japan 12.6.4. Australia & New Zealand 12.6.5. Rest of Asia Pacific 12.7. Asia Pacific Market Attractiveness Analysis 12.7.1. By Test Type 12.7.2. By Service Providers 12.7.3. By Applications 12.7.4. By Country 13. Latin America Market Analysis 13.1. Latin America Market Key Findings 13.2. Latin America Market Overview 13.3. Latin America Cytometry Market Size and Forecast, by Test Type 13.3.1. Prenatal Testing Services 13.3.2. New Born Screening 13.3.3. Predictive and Presymptomatic Testing 13.3.4. Pharmacogenomic Testing 13.3.5. Others 13.4. Latin America Market Size and Forecast, by Service Providers 13.4.1. Hospital Based Laboratories 13.4.2. Diagnostic laboratories 13.4.3. Specialty Clinics 13.4.4. Others 13.5. Latin America Market Forecast, by Country 13.5.1. Brazil 13.5.2. Mexico 13.5.3. Rest of Latin America 13.6. Latin America Market Forecast, by Applications 13.6.1. Oncology 13.6.2. Infectious Diseases 13.6.3. Autoimmune Diseases 13.6.4. Others 13.7. Latin America Market Attractiveness Analysis 13.7.1. By Test Type 13.7.2. By Service Providers 13.7.3. By Applications 13.7.4. By Country 14. Middle East & Africa Market Analysis 14.1. Middle East & Africa Market Key Findings 14.2. Middle East & Africa Market Overview 14.3. Middle East & Africa Cytometry Market Size and Forecast, by Test Type 14.3.1. Prenatal Testing Services 14.3.2. New Born Screening 14.3.3. Predictive and Presymptomatic Testing 14.3.4. Pharmacogenomic Testing 14.3.5. Others 14.4. Middle East & Africa Market Size and Forecast, by Service Providers 14.4.1. Hospital Based Laboratories 14.4.2. Diagnostic laboratories 14.4.3. Specialty Clinics 14.4.4. Others 14.5. Middle East & Africa Market Forecast, by Applications 14.5.1. Oncology 14.5.2. Infectious Diseases 14.5.3. Autoimmune Diseases 14.5.4. Others 14.6. Middle East & Africa Market Size and Forecast, by Country 14.6.1. GCC Countries 14.6.2. Israel 14.6.3. South Africa 14.6.4. Rest of Middle East & Africa 14.7. Middle East Market Attractiveness Analysis 14.7.1. By Test Type 14.7.2. By Service Providers 14.7.3. By Applications 14.7.4. By Country 15. Competition Landscape 15.1. Global Market Share Analysis, by Company (2022) 15.2. Company Profiles 15.2.1. Laboratory Corporation of America Holdings 15.2.1.1. Overview (HQ, Employee Strength, Business Segments) 15.2.1.2. Financials 15.2.1.3. Recent Developments 15.2.1.4. Strategy 15.2.2. Quest Diagnostics Incorporated 15.2.2.1. Overview (HQ, Employee Strength, Business Segments) 15.2.2.2. Financials 15.2.2.3. Recent Developments 15.2.2.4. Strategy 15.2.3. Genomic Health, Inc. 15.2.3.1. Overview (HQ, Employee Strength, Business Segments) 15.2.3.2. Financials 15.2.3.3. Recent Developments 15.2.3.4. Strategy 15.2.4. NeoGenomics Laboratories, Inc. 15.2.4.1. Overview (HQ, Employee Strength, Business Segments) 15.2.4.2. Financials 15.2.4.3. Recent Developments 15.2.4.4. Strategy 15.2.5. Eurofins Scientific 15.2.5.1. Overview (HQ, Employee Strength, Business Segments) 15.2.5.2. Financials 15.2.5.3. Recent Developments 15.2.5.4. Strategy 15.2.6. Ambry Genetics 15.2.6.1. Overview (HQ, Employee Strength, Business Segments) 15.2.6.2. Financials 15.2.6.3. Recent Developments 15.2.6.4. Strategy 15.2.7. F. Hoffmann-La Roche Ltd 15.2.7.1. Overview (HQ, Employee Strength, Business Segments) 15.2.7.2. Financials 15.2.7.3. Recent Developments 15.2.7.4. Strategy 15.2.8. Illumina, Inc 15.2.8.1. Overview (HQ, Employee Strength, Business Segments) 15.2.8.2. Financials 15.2.8.3. Recent Developments 15.2.8.4. Strategy 15.2.9. CENTOGENE AG 15.2.9.1. Overview (HQ, Employee Strength, Business Segments) 15.2.9.2. Financials 15.2.9.3. Recent Developments 15.2.9.4. Strategy 15.2.10. 23andMe, Inc. 15.2.10.1. Overview (HQ, Employee Strength, Business Segments) 15.2.10.2. Financials 15.2.10.3. Recent Developments 15.2.10.4. Strategy
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 01: Global Market Value (US$ Mn) Forecast, by Test Type, 2023–2033
Table 02: Global Market Value (US$ Mn) Forecast, by Service Provider, 2023–2033
Table 03: Global Market Value (US$ Mn) Forecast, by Applications, 2023–2033
Table 04: Global Market Size (US$ Mn) Forecast, by Region, 2023–2033
Table 05: North America Market Value (US$ Mn) Forecast, by Test Type, 2023–2033
Table 06: North America Market Value (US$ Mn) Forecast, by Service Providers,
Table 07: North America Market Value (US$ Mn) Forecast, by Applications,
Table 08: North America Market Value (US$ Mn) Forecast, by Country, 2023–2033
Table 09: Europe Market Value (US$ Mn) Forecast, by Test Type, 2023–2033
Table 10: Europe Market Value (US$ Mn) Forecast, by Service Providers,
Table 11: Europe Market Value (US$ Mn) Forecast, by Applications,
Table 12: Europe Market Value (US$ Mn) Forecast, by Country, 2023–2033
Table 13: Asia Pacific Market Value (US$ Mn) Forecast, by Test Type, 2023–2033
Table 14: Asia Pacific Market Value (US$ Mn) Forecast, by Service Providers,
Table 15: Asia Pacific Market Value (US$ Mn) Forecast, by Applications,
Table 16: Asia Pacific Market Value (US$ Mn) Forecast, by Country, 2023–2033
Table 17: Latin America Market Value (US$ Mn) Forecast, by Test Type, 2023–2033
Table 18: Latin America Market Value (US$ Mn) Forecast, by Service Providers,
Table 19: Latin America Market Value (US$ Mn) Forecast, by Applications,
Table 20: Latin America Market Value (US$ Mn) Forecast, by Country, 2023–2033
Table 21: Middle East & Africa Market Value (US$ Mn) Forecast, by Test Type, 2023–2033
Table 22: Middle East & Africa Market Value (US$ Mn) Forecast, by Service Providers,
Table 23: Middle East & Africa Market Value (US$ Mn) Forecast, by Service Applications
Table 24: Middle East & Africa Market Value (US$ Mn) Forecast, by Country, 2023–2033
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 01: Global Genetic Testing Services, by Test Type, Market Size (US$ Mn), 2022 (A)
Figure 02: Global Market Revenue (%), by Service Providers, 2022 (A)
Figure 03: Distribution of Market by Region, 2023 and 2033
Figure 04: Key Industry Developments
Figure 05: Global Market Size (US$ Mn) Forecast, 2023–2033
Figure 06: Porter’s Five Forces Analysis
Figure 07: Global Market Value Share, by Test Type (2022)
Figure 08: Global Market Value Share, by Service Providers (2022)
Figure 09: Global Market Value Share, by Applications (2022)
Figure 10: Global Market Value Share Analysis, by Test Type, 2023 and 2033
Figure 11: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Prenatal Testing, 2023–2033
Figure 12: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%), by New Born Screening
Figure 13: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Predictive and Presymptomatic Testing, 2023–2033
Figure 14: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Human and Tumor Genetics, 2023–2033
Figure 15: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Other, 2023–2033
Figure 16: Global Market Attractiveness Analysis, by Test Type
Figure 17: Global Market Value Share Analysis, by Service Provider, 2023 and 2033
Figure 18: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hospital Based Laboratories, 2023–2033
Figure 19: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Diagnostic Laboratories, 2023–2033
Figure 20: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Specialty Clinics, 2023–2033
Figure 21: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2023–2033
Figure 22: Global Market Attractiveness Analysis, by Service Provider
Figure 23: Global Market Value Share Analysis, by Applications, 2023 and 2033
Figure 24: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Oncology, 2023–2033
Figure 25: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Infectious Disease, 2023–2033
Figure 26: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Autoimmune Disease, 2023–2033
Figure 27: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2023–2033
Figure 28: Global Market Attractiveness Analysis, by Applications
Figure 29: Global Market Scenario
Figure 30: Global Market Value Share Analysis, by Region, 2023 and 2033
Figure 31: Global Market Attractiveness Analysis, by Region
Figure 32: North America Market Size (US$ Mn) Forecast, 2023–2033
Figure 33: North America Market Attractiveness Analysis,
Figure 34: North America Market Value Share Analysis, by Test Type, 2023 and 2033
Figure 35: North America Market Value Share Analysis, by Service Providers, 2023 and 2033
Figure 36: North America Market Value Share Analysis, by Applications, 2023 and 2033
Figure 37: North America Market Value Share Analysis, by Country, 2023 and 2033
Figure 38: North America Market Attractiveness Analysis, by Test types, 2023–2033
Figure 39: North America Market Attractiveness Analysis, by Service Providers, 2023–2033
Figure 40: North America Market Attractiveness Analysis, by Applications, 2023–2033
Figure 41: Europe Market Size (US$ Mn) Forecast, 2023–2033
Figure 42: Europe Market Attractiveness Analysis,
Figure 43: Europe Market Value Share Analysis, by Test Type, 2023 and 2033
Figure 44: Europe Market Value Share Analysis, by Service Providers, 2023 and 2033
Figure 45: Europe Market Value Share Analysis, by Applications, 2023 and 2033
Figure 46: Europe Market Value Share Analysis, by Country, 2023 and 2033
Figure 47: Europe Market Attractiveness Analysis, by Test types, 2023–2033
Figure 48: Europe Market Attractiveness Analysis, by Service Providers, 2023–2033
Figure 49: Europe Market Attractiveness Analysis, by Applications, 2023–2033
Figure 50: Asia Pacific Market Size (US$ Mn) Forecast, 2023–2033
Figure 51: Asia Pacific Market Attractiveness Analysis,
Figure 52: Asia Pacific Market Value Share Analysis, by Test Type, 2023 and 2033
Figure 53: Asia Pacific Market Value Share Analysis, by Service Providers, 2023 and 2033
Figure 54: Asia Pacific Market Value Share Analysis, by Applications, 2023 and 2033
Figure 55: Asia Pacific Market Value Share Analysis, by Country, 2023 and 2033
Figure 56: Asia Pacific Market Attractiveness Analysis, by Test types, 2023–2033
Figure 57: Asia Pacific Market Attractiveness Analysis, by Service Providers, 2023–2033
Figure 58: Asia Pacific Market Attractiveness Analysis, by Applications, 2023–2033
Figure 59: Latin America Market Size (US$ Mn) Forecast, 2023–2033
Figure 60: Latin America Market Attractiveness Analysis,
Figure 61: Latin America Market Value Share Analysis, by Test Type, 2023 and 2033
Figure 62: Latin America Market Value Share Analysis, by Service Providers, 2023 and 2033
Figure 63: Latin America Market Value Share Analysis, by Applications, 2023 and 2033
Figure 64: Latin America Market Value Share Analysis, by Country, 2023 and 2033
Figure 65: Latin America Market Attractiveness Analysis, by Test types, 2023–2033
Figure 66: Latin America Market Attractiveness Analysis, by Service Providers, 2023–2033
Figure 67: Latin America Market Attractiveness Analysis, by Applications, 2023–2033
Figure 68: Middle East & Africa Market Size (US$ Mn) Forecast, 2023–2033
Figure 69: Middle East & Africa Market Attractiveness Analysis,
Figure 70: Middle East & Africa Market Value Share Analysis, by Test Type, 2023 and 2033
Figure 71: Middle East & Africa Market Value Share Analysis, by Service Providers, 2023 and 2033
Figure 72: Middle East & Africa Market Value Share Analysis, by Applications, 2023 and 2033
Figure 73: Middle East & Africa Market Value Share Analysis, by Country, 2023 and 2033
Figure 74: Middle East & Africa Market Attractiveness Analysis, by Test types, 2023–2033
Figure 75: Middle East & Africa Market Attractiveness Analysis, by Service Providers, 2023–2033
Figure 76: Middle East & Africa Market Attractiveness Analysis, by Applications, 2023–2033
Figure 77: Laboratory Corporation of America Holdings. Revenue (US$ Bn) and Y-o-Y Growth (%), 2022–2022
Figure 78: Laboratory Corporation of America Holdings. Net Sales, By Geography, 2022
Figure 79: Laboratory Corporation of America Holdings. Breakdown of Net Sales, By Segment, 2022
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request